NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
12/17/2025
Back to search
Official data from USPTO
ENTERIC DIALYSIS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ENTERIC DIALYSIS
ST13
US500000076610241Class
44
Filing
76610241
Registration
3005195
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
32
Latest update
01/06/2026
Trademark type
Word
Nice classes
44
Filing date
09/07/2004
Registration date
10/04/2005
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/17/2025
Last transaction
01/06/2026
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Supplemental Register
First use anywhere
2002-10-00
First use in commerce
2002-10-00
Drawing code
4
Owner type
16
Owner location
EXTON, PA
Examiner
BELENKER, ESTHER
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
KIBOW BIOTECH LLC
Kibow Biotech, Inc.
Kibow Biotech, Inc.
Representatives
Kathleen A. Tyrrell LICATA & TYRRELL P.C.
Technical classification
Nice Classes
Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 44
Medical services for the elimination of uremic toxins in the bowel
Publications
History of USPTO decisions and trademark events.
32 publications found
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
12/17/2025
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
12/17/2025
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
12/17/2025
PR89
POST REGISTRATION ACTION MAILED - SEC. 8 & 9
12/09/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/09/2025
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
09/10/2025
E89R
TEAS SECTION 8 & 9 RECEIVED
08/27/2025
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
10/04/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/22/2019
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
10/22/2019
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
05/21/2015
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
05/21/2015
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
05/21/2015
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/21/2015
E89R
TEAS SECTION 8 & 9 RECEIVED
05/04/2015
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
09/30/2011
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
09/30/2011
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/28/2011
ES8R
TEAS SECTION 8 RECEIVED
09/27/2011
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
02/08/2006
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
10/04/2005
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
08/24/2005
ALIE
ASSIGNED TO LIE
08/19/2005
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
08/15/2005
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/15/2005
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/09/2005
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/09/2005
GNRT
NON-FINAL ACTION E-MAILED
04/22/2005
CNRT
NON-FINAL ACTION WRITTEN
04/22/2005
DOCK
ASSIGNED TO EXAMINER
04/04/2005
NWAP
NEW APPLICATION ENTERED
09/15/2004
Continuous trademark protection
Get notified about every new filing that threatens ENTERIC DIALYSIS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.